BAX | Baxter InternationalNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history

$25.49
+$1.27 (+5.24%)

Baxter International (BAX) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat above the 200 on the daily since Jul 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits above the 50 and the 200; on the weekly it is between the two.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $25.49 vs 50 $24.52 / 200 $21.38
Projection
No cross projected
Test
No active test
Last cross
Golden cross 13 Jul 2026 ยท projected 24 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $23.00 vs 50 $20.96 / 200 $31.94
Projection
No cross projected
Test
No active test
Last cross
Death cross week of 16 May 2022 ยท projected 13 bars out

4-hour as of 3 Nov 16:00 ET

Price
above both $25.49 vs 50 $24.53 / 200 $24.12
Projection
No cross projected
Test
No active test
Last cross
Golden cross 11 Jun 2026 ยท projected 20 bars out

Cross history

28
crosses on record since 2018
14 golden14 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
13 Jul 2026Golden steepdaily24 bars outNot tested
11 Jun 2026Golden4-hour20 bars outNot tested
18 Mar 2026Death4-hour24 bars outNot tested
11 Feb 2026Golden4-hour20 bars out3 bar cross test
16 Apr 2025Death4-hour28 bars outโ€”

About BAX

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$137M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.